Herm Rosenman

Mr. Herman Rosenman is an Independent Director at DermTech, Inc. and an Independent Director at Natera, Inc. He is on the Board of Directors at DermTech, Inc., Natera, Inc., Oxford Immunotec Ltd., Quest Diagnostics TB LLC and Renaissance Medical Group, Inc. Mr. Rosenman was previously employed as an Independent Non-Executive Director by Oxford Immunotec Global Ltd., an Independent Director by VIVUS, Inc., a Chief Financial Officer & SVP-Finance by Gen-Probe, Inc., a President & Chief Executive Officer by Ultra Acquisition Corp., a President & Chief Executive Officer by RadNet Management, Inc., a Partner by Coopers & Lybrand LLP, and a Chief Financial Officer by Rexene Corp.
He also served on the board at DermTech, Inc. /Old/, Medistem, Inc., Biofire Diagnostics LLC, Emphasys Medical, Inc., ARYx Therapeutics, Inc., Infinity Pharmaceuticals, Inc. and Discovery Partners International, Inc. He received his undergraduate degree from Pace University and an MBA from The Wharton School of the University of Pennsylvania.